Outline as of January 11, 2022

Corporate Name
Kobayashi Foundation for Cancer Research
Office
1-27, Kanda Nishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan
Date of Foundation
December 9, 2008
Purpose of Establishment
The purpose of Kobayashi Foundation for Cancer Research is to promote academic fields and science technologies in the field of cancer treatment and contribute to the development and improvement of cancer treatment by making grants/giving awards to innovative/pioneering cancer treatments about cancer chemotherapy, giving awards to outstanding social activities in the field of cancer treatment and making grants to human resource cultivation through the promotion of the latest academic information.
Activities
  1. Making grants and giving awards to innovative treatments about cancer chemotherapy.
  2. Giving awards to remarkable social contributions in the field of cancer treatment.
  3. Making grants to pioneering treatments about cancer chemotherapy.
  4. Holding symposia on the latest cancer chemotherapy and making grants to promotion activities through publications.
  5. Other businesses to achieve our objectives.
Chairman of the Council
Tadao KakizoePresident, The Japan Cancer Society
Councilor
Teijiro FurukawaFormer Chairman of the Board of Directors, Imperial Gift Foundation Boshi-Aiiku-Kai
Former Deputy Chief Cabinet Secretary
Takeo SekiyaChairman of the Board of Directors, Princess Takamatsu Cancer Research Fund
Michihiko KuwanoProfessor Emeritus, Kyushu University
Masayuki KobayashiExecutive Director, Otsuka Holdings Co., Ltd.
President & Representative Director, Taiho Pharmaceutical Co., Ltd.
Chairman of the Board of Directors
Teruhiro UtsugiSenior Managing Director, Board Member
Discovery & Preclinical Research Division, Intellectual Property
Taiho Pharmaceutical Co., Ltd.
Director
Tatsuji IgaProfessor Emeritus, The University of Tokyo Former President, The Japanese Society of Hospital Pharmacists
Misako KojimaFormer President, Seirei Christopher University Former President, The Japanese Society of Cancer Nursing
Morito MondenPresident, Sakai City Medical Center
President, the Japanese Association of Medical Sciences
Ryuzo UedaProfessor, Tumor Immunology, School of Medicine, Aichi Medical University
Professor Emeritus, Nagoya City University
Auditor
Tsuguo TakahashiCertified Public Accountant
Adviser
Tetsuo TaguchiProfessor Emeritus, Osaka University
Yukio KobayashiExecutive Advisor, Taiho Pharmaceutical Co., Ltd.
Takao OhnumaDivision of Hematology and Oncology Mount Sinai School of Medicine Professor of Medicine